Chemoinformaics analysis of (S)-N-(3,4-Dimethoxybenzyl)-1-phenylethanamine-
Molecular Weight | 271.36 | nRot | 6 |
Heavy Atom Molecular Weight | 250.192 | nRig | 12 |
Exact Molecular Weight | 271.157 | nRing | 2 |
Solubility: LogS | -2.194 | nHRing | 0 |
Solubility: LogP | 2.639 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 2 |
Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 41 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 20 | No. of Aromatic Carbocycles | 2 |
nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 21 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 17 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 1 | No. of Arom Atom | 12 |
No. of Oxygen atom | 2 | No. of Arom Bond | 12 |
nHA | 3 | APOL | 45.0967 |
nHD | 1 | BPOL | 25.1093 |
QED | 0.871 |
Synth | 2.003 |
Natural Product Likeliness | -0.69 |
NR-PPAR-gamma | 0.001 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.829 |
Pgp-sub | 0.055 |
HIA | 0.004 |
CACO-2 | -4.532 |
MDCK | 0.0000187 |
BBB | 0.724 |
PPB | 0.776694 |
VDSS | 2.289 |
FU | 0.0998543 |
CYP1A2-inh | 0.744 |
CYP1A2-sub | 0.941 |
CYP2c19-inh | 0.869 |
CYP2c19-sub | 0.92 |
CYP2c9-inh | 0.05 |
CYP2c9-sub | 0.631 |
CYP2d6-inh | 0.971 |
CYP2d6-sub | 0.93 |
CYP3a4-inh | 0.761 |
CYP3a4-sub | 0.683 |
CL | 7.8 |
T12 | 0.685 |
hERG | 0.106 |
Ames | 0.087 |
ROA | 0.672 |
SkinSen | 0.076 |
Carcinogencity | 0.045 |
EI | 0.02 |
Respiratory | 0.062 |
NR-Aromatase | 0.012 |
Antiviral | No |
Prediction | 0.709815 |